In patients, exosomal miR-1910-3p was significantly higher in the serum of breast cancer patients than in that of healthy volunteers and acted by downregulating MTMR3 and activating the NF-κB signaling pathway [125]. The gene discussed is NFKB1; the disease is breast carcinoma.